The characterization of a novel V1b antagonist lead series

被引：3
|
作者：
Smethurst, Chris A. [1 ]
Borthwick, Jennifer A. [1 ]
Gaines, Simon [1 ]
Watson, Steve [1 ]
Green, Andrew [1 ]
Schulz, Mark J.
Burton, George
Buson, Alberto A. [2 ]
Arban, Roberto [2 ]
机构：
[1] GlaxoSmithKline Res & Dev Ltd, Harlow, Essex, England
[2] GlaxoSmithKline Res & Dev Ltd, Verona, Italy
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 01期
关键词：
Vasopressin; Anxiety; Depression; VASOPRESSIN; STRESS;
D O I：
10.1016/j.bmcl.2010.11.061
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The SAR around a V1b antagonist HTS hit 3 was explored to produce a series of thiazole sulfonamides as a lead series with selectivity over the related V1 and oxytocin receptors. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：92 / 96
页数：5
相关论文
共 50 条
  • [1] Characterization of a novel and selective V1B receptor antagonist
    Craighead, Mark
    Milne, Rachel
    Campbell-Wan, Leigh
    Watson, Lynn
    Presland, Jeremy
    Thomson, Fiona J.
    Marston, Hugh M.
    MacSweeney, Cliona P.
    ADVANCES IN VASOPRESSIN AND OXYTOCIN: FROM GENES TO BEHAVIOUR TO DISEASE, 2008, 170 : 527 - 535
  • [2] Functional and pharmacological characterization of the first specific agonist and antagonist for the V1B receptor in mammals
    Claudine, SLG
    Sylvain, D
    Gabrielle, B
    Maurice, M
    Jacques, S
    Rolf, G
    Guy, G
    Gilles, G
    STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 2003, 6 (03): : 199 - 206
  • [3] Resolving the Mystery of Corticotropinoma using Radiolabeled V1b Receptor Antagonist
    Pandey, Somit
    Walia, Rama
    Gill, Gurvinder
    Rana, Nivedita
    Pandav, Kumud
    Kumar, Rajender
    Mittal, Bhagwant
    Shukla, Jaya
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [4] Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior
    Hodgson, Robert A.
    Mullins, Deborra
    Lu, Sherry X.
    Guzzi, Mario
    Zhang, Xiaoping
    Bleickardt, Carina J.
    Scott, Jack D.
    Miller, Michael W.
    Stamford, Andrew W.
    Parker, Eric M.
    Varty, Geoffrey B.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 730 : 157 - 163
  • [5] Characterization of vasopressin V1b receptor deficient mouse
    Oshikawa, S
    Tanoue, A
    Ito, S
    Fukuda, M
    Yamamoto, K
    Tsujimoto, G
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 213P - 213P
  • [6] ANC-501, A Novel V1B Receptor Antagonist: Association of MDD Response With MADRS Subscales
    Kanes, Stephen
    Perera, Philip
    Zipkin, Ilan
    Dennie, Lara
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 193 - 194
  • [7] ANC-501, A Novel V1B Receptor Antagonist: Association of MDD Response With MADRS Subscales
    Kanes, Stephen
    Perera, Philip
    Zipkin, Ilan
    Dennie, Lara
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 193 - 194
  • [8] ANC-501-A Novel V1b Receptor Antagonist: Results of a Personalized Phase 2 Trial in MDD
    Kanes, Stephen
    Dev, Vikram
    Wilson, Ellis
    Kelly, Noel
    Perera, Philip
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 206 - 207
  • [9] 1,3-Dihydro-2H-indol-2-one derivatives as novel vasopressin V1b antagonists: Lead optimization and pharmacological effects of the potent V1b antagonists in animal models
    Yoshinaga, Mitsukane
    Kuwada, Takeshi
    Nozawa, Dai
    Shibata, Tsuyoshi
    Hayashi, Masato
    Amada, Yuri
    Yamamoto, Shuji
    Sekiguchi, Yoshinori
    Iijima, Michihiko
    Yoshimizu, Takao
    Yamaguchi, Jun-ichi
    Chaki, Shigeyuki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [10] Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand
    Serradeil-Le Gal, Claudine
    Raufaste, Daniele
    Derick, Sylvain
    Blankenstein, Joerg
    Allen, John
    Pouzet, Brigitte
    Pascal, Marc
    Wagnon, Jean
    Ventura, Maria Angeles
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2007, 293 (02) : R938 - R949
12345